Skip Nav Destination
1-20 of 22
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)
P. Sonneveld, B. van der Holt, I. G.H. Schmidt-Wolf, U. Bertsch, L. el Jarari, Hans-Jürgen Salwender, S. Zweegman, E. Vellenga, J. Schubert, I. W. Blau, GSK Jie, B. Beverloo, A. Jauch, D. Hose, R. Schaafsma, M. J. Kersten, M. Delforge, O. de Weerdt, R. van der Griend, P. W. Wijermans, Hans Martin, H. van der Velde, Henk M. Lokhorst, H. Goldschmidt
Blood (2008) 112 (11): 653.
Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.
L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Blood (2005) 106 (11): 544.
Use of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor During and After Remission Induction Chemotherapy in Patients Aged 61 Years and Older With Acute Myeloid Leukemia (AML): Final Report of AML-11, a Phase III Randomized Study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)
B. Löwenberg, S. Suciu, E. Archimbaud, G. Ossenkoppele, G.E.G. Verhoef, E. Vellenga, P. Wijermans, Z. Berneman, A.W. Dekker, P. Stryckmans, H. Schouten, U. Jehn, P. Muus, P. Sonneveld, M. Dardenne, R. Zittoun
Blood (1997) 90 (8): 2952–2961.
The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36- sorted bone marrow cells of myelodysplasia patients
Blood (1996) 88 (2): 505–510.
Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway
Blood (1996) 87 (2): 691–698.
Blood (1995) 86 (3): 900–905.
Blood (1994) 84 (5): 1434–1441.
Blood (1994) 84 (2): 608–615.
Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation
Blood (1994) 84 (1): 59–64.
Interleukin-4 inhibits the lipopolysaccharide-induced expression of c- jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes
Blood (1993) 81 (2): 337–343.
Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells
Blood (1993) 81 (1): 35–40.
Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level
Blood (1992) 80 (11): 2721–2728.
B Biesma, PH Willemse, NH Mulder, DT Sleijfer, JA Gietema, R Mull, PC Limburg, J Bouma, E Vellenga, EG de Vries
Blood (1992) 80 (5): 1141–1148.
Divergent effects of interleukin-4 (IL-4) on the granulocyte colony- stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells
Blood (1990) 75 (3): 633–637.
Correction of granulocytopenia in Felty's syndrome by granulocyte- macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis
Blood (1989) 74 (8): 2769–2770.
Blood (1988) 71 (6): 1529–1532.
Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor- dependent mechanism
Blood (1988) 71 (3): 672–676.
Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors
Blood (1987) 70 (4): 1218–1221.
The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia
Blood (1987) 69 (6): 1771–1776.
The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood
Blood (1986) 67 (3): 616–622.